ACCacia, une approche de machine-learning pour la classification moléculaire des corticosurrénalomes en routine clinique
V. Gravrand(Inserm), Guillaume Assié(Centre National de la Recherche Scientifique), Jérôme Bertherat(Centre National de la Recherche Scientifique), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), E. Sonnet(Centre Hospitalier Régional Universitaire de Brest), Laura Bessiène(Hôpital Cochin), K. Perlemoine(Inserm), Fidéline Bonnet-Serrano(Centre National de la Recherche Scientifique), Mohand Lyazid Benkhellat(Inserm), F. Castinetti, Florian Violon(Centre National de la Recherche Scientifique), D. Drui(Centre Hospitalier Universitaire de Nantes), S. Laboureau, Nesrine Benanteur(Inserm), E. Baudin(Institut Gustave Roussy), Charlotte Lussey‐Lepoutre(Inserm), Lucas Bouys, Hervé Lefèbvre(Inserm), Laurence Guignat(Hôpital Cochin), Mathilde Sibony(Environmental Protection Agency), Rossella Libé(Hôpital Cochin), Franck Letourneur(Inserm), Lionel Groussin(Université Paris Cité), Patricia Vaduva(Université Rennes 2), Antoine Tabarin(Université de Bordeaux), A. Jouinot, B. Goichot, Martin Gaillard(Inserm), Justine Cristante(Centre Hospitalier Universitaire de Grenoble), Laurence Amar(Unit of Functional and Adaptive Biology), Hélène Lasolle(Hospices Civils de Lyon), A. Jannin(Centre Hospitalier Universitaire de Lille), M.F. Birtolo(Inserm), Lucie Adoux(Inserm), Anna Vaczlavik(Hôpital Cochin)
Cited by 0
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772